Related Experiment Video
Updated: Sep 28, 2026

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
Increase in accumbal dopaminergic transmission correlates with response cost not reward of hypothalamic stimulation
Darryl B Neill1, Howard Fenton, Joseph B Justice
1Department of Psychology, Emory University, Atlanta, GA 30322, USA. dneill@emory.edu
Abstract:
Rats were trained to lever-press for intracranial self-stimulation (ICSS) of the lateral hypothalamus on either a fixed ratio (FR) 1 or 10 schedule. Their brains were removed after a 20 min session and tissue punches taken from the nucleus accumbens, olfactory tubercle, anterior striatum, or central striatum. These punches were assayed for content of dopamine (DA) and the major DA metabolite DOPAC. Compared with implanted controls, only the FR10 group showed significantly elevated DOPAC/DA ratios. These elevations were statistically significant in nucleus accumbens and central striatum and near significance in anterior striatum. They occurred to similar degrees in each hemisphere. In contrast, we found that stimulation of the ventral tegmental area of anesthetized rats asymmetrically increased the DOPAC/DA ratio, being most prominent in the ipsilateral accumbens. Because the FR10 group made only 58% of the responses of the FR1 group and received only 6% of the stimulations of the FR1 group, yet unlike the FR1 group showed a significant increase in the DOPAC/DA ratio, we suggest that the DA release was primarily influenced by the schedule, not the stimulation or the reward of the stimulation. These results were interpreted in terms of a model in which hypothalamic ICSS reward is largely dependent on non-dopaminergic mechanisms, with accumbal DA transmission being strongly dependent on the costs versus benefits of ongoing behavior.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Dose-Response Relationship: Overview

